CDEK by Data4ThePeople
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
Drugs
Search by NameFDA Approval TrendsAdvanced SearchFDA Approved Drugs
Organizations
Search by NameOrganization TrendsAdvanced Search
IndicationsMechanismsTrialsFDA Approvals
About
About CDEKGlossaryAdvanced Search GuideSearch by Name
← All indications

Herpesvirus 4, Human

The type species of LYMPHOCRYPTOVIRUS, subfamily GAMMAHERPESVIRINAE, infecting B-cells in humans. It is thought to be the causative agent of INFECTIOUS MONONUCLEOSIS and is strongly associated with oral hairy leukoplakia (LEUKOPLAKIA, HAIRY;), BURKITT LYMPHOMA; and other malignancies.

Drugs by status

Phase 4 trials (3)

  • tacrolimus
  • belatacept
  • mycophenolate

Phase 3 trials (3)

  • methylprednisolone
  • doxorubicin
  • etoposide

Phase 2 trials (7)

  • cmd-003
  • valaciclovir
  • ifnγ- positive selected t-cells
  • camrelizumab
  • tabelecleucel
  • toripalimab
  • chidamide

Phase 1 trials (11)

  • qs-21
  • allogeneic multivirus - directed cytotoxic t lymphocytes
  • cytotoxic t cells
  • nelfinavir
  • virus-specific T cells
  • matrix m1
  • saponin
  • ebv gp350-ferritin vaccine
  • r-mvst
  • ksd-101
  • ebv gh/gl/gp42-ferritin nanoparticle vaccine

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.